Top compounds associated with response to LINC00176


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel gCSI pan-cancer AAC -0.15 0.004
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.1 0.004
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA XL765 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.095 0.005
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.099 0.005
mRNA pac-1 CTRPv2 pan-cancer AAC 0.098 0.006
mRNA C6-ceramide CTRPv2 pan-cancer AAC 0.1 0.006
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.006
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.09 0.007
Download CSV